: Cornell partially shuts down its campus due to nearly 500 COVID-19 cases in possible omicron outbreak

This post was originally published on this site

Cornell University is partially shutting down its Ithaca, N.Y., campus due to a “rapid spread” of COVID-19 cases among the student body, the Ivy League school announced Tuesday

The university’s online COVID dashboard counted 469 active student cases as of Tuesday afternoon. 

University president Martha E. Pollack posted a statement online updating the campus community to the worsening COVID outbreak on Tuesday. And she revealed that lab tests have identified evidence of the highly contagious omicron variant in a “significant number” of Monday’s COVID-19 positive student samples. But she cautioned that their evidence of omicron is “preliminary” after PCR testing identified a genetic marker that has been identified as a hallmark of the omicron variant. So while the school awaits confirmatory sequencing information, it is proceeding as if omicron is the source of the outbreak. 

“As a result, and out of an abundance of caution, the university is moving to Alert Level Red and announcing a number of immediate measures, outlined below,” she wrote. 

The emergency measures include moving all final exams online as of noon on Tuesday. 

All undergraduate university activities and university-sponsored events are canceled — and that includes the Dec. 18 graduation ceremony for December graduates. 

Students who have tested negative for COVID-19 within the past 48 hours (Saturday or Sunday) who wish to leave campus are allowed, and they are encouraged to wear face masks and take another COVID-19 test when they reach their destination, and self-quarantine until they learn the results. 

Students who have not tested negative for COVID within the past 48 hours are advised to get tested ASAP and stay in Ithaca, in their residences, and to “severely limit” their interactions with others until they get their COVID test results. 

In the meantime, visitors and guests are not allowed on campus, except for those picking up students for the winter break. And those visitors are urged to keep their masks on. 

Finally, mandatory COVID testing will continue as normal for employees. 

“While I want to provide reassurance that, to date, we have not seen severe illness in any of our infected students, we do have a role to play in reducing the spread of the disease in the broader community,” Pollack wrote. 

Cornell’s last full day of classes was Dec. 7, and final exams are scheduled through Dec. 18. 

The news comes the same day that Pfizer Inc.
PFE,
+0.65%

shared some possible good news in the fight against the novel coronavirus: final data from a late-stage trial of its COVID-19 antiviral drug paxlovid found that it reduced the risk of hospitalization or death in high-risk adults by 89% if given shortly after the onset of symptoms, confirming the first set of data released last month.

Read more: Pfizer’s COVID-19 antiviral proves almost 90% effective in latest trial data, as U.S. passes 50 million confirmed cases of the illness

What’s more, the trial found that paxlovid was effective in treating the omicron variant in lab studies. The World Health Organization has warned that omicron is spreading faster than any prior variant and could overwhelm health systems, even if cases remain milder.

The U.S. is still averaging almost 1,300 deaths a day from COVID, according to a Times tracker, and cases and hospitalizations are rising. On Tuesday, the U.S. passed 50 million confirmed cases of COVID.